Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy

被引:2
|
作者
Arouche-Delaperche, L. [1 ]
Cadoni, S. [1 ]
Joffrois, C. [1 ]
Labernede, G. [1 ]
Valet, M. [1 ]
Cesar, Q. [1 ]
Degardin, J. [1 ]
Girardon, S. [2 ]
Gabriel, C. [3 ]
Krantic, S. [4 ]
Picaud, S. [1 ]
机构
[1] Sorbonne Univ, Inst Vis, INSERM, CNRS, 17 Rue Moreau, F-75012 Paris, France
[2] Inst Rech Servier, 125 Chemin Ronde, F-78290 Croissy Sur Seine, France
[3] Inst Rech Internatl Servier, 50 Rue Carnot, F-92284 Suresnes, France
[4] Sorbonne Univ, INSERM UMRS 938, Ctr Rech St Antoine, CRSA, 184 Rue Faubourg St Antoine, F-75012 Paris, France
基金
欧洲研究理事会;
关键词
Retina; Phosphorylated tau; Alzheimer's disease; P301S mouse; Synapsis; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; MEMORY DEFICITS; TAU; MICE; NETWORK; HYPEREXCITABILITY; ABNORMALITIES; IMPAIRMENT; RELEASE;
D O I
10.1186/s40478-022-01489-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tauopathies, including Alzheimer's disease, are characterized by retinal ganglion cell loss associated with amyloid and phosphorylated tau deposits. We investigated the functional impact of these histopathological alterations in the murine P301S model of tauopathy. Visual impairments were demonstrated by a decrease in visual acuity already detectable at 6 months, the onset of disease. Visual signals to the cortex and retina were delayed at 6 and 9 months, respectively. Surprisingly, the retinal output signal was delayed at the light onset and advanced at the light offset. This antagonistic effect, due to a dysfunction of the cone photoreceptor synapse, was associated with changes in the expression of the vesicular glutamate transporter and a microglial reaction. This dysfunction of retinal glutamatergic synapses suggests a novel interpretation for visual deficits in tauopathies and it highlights the potential value of the retina for the diagnostic assessment and the evaluation of therapies in Alzheimer's disease and other tauopathies.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Pathology of a transgenic mouse expressing human P301S tau
    Murrell, Jill
    Gnezda, Anita
    Green, Alexis
    Greally, John
    Grahame, Nicholas
    Ghetti, Bernardino
    BRAIN PATHOLOGY, 2006, 16 : S44 - S44
  • [32] Progressive tauopathy in P301S tau transgenic mice is associated with a functional deficit of the olfactory system
    Yang, Sujeong
    Kuan, Wei-Li
    Spillantini, Maria Grazia
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2016, 44 (06) : 2396 - 2403
  • [33] Characterization of a transgenic mouse expressing human P301S tau.
    Gnezda, AG
    Behm, A
    Greally, J
    Grahame, N
    Ghetti, B
    Murrell, JR
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (05): : 471 - 471
  • [34] Tau pathology and motor disturbances in the human tau P301S transgenic mouse model.
    Murrell, JR
    Takao, M
    Ghetti, B
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 519 - 519
  • [35] Ibuprofen increases the longevity and reduces the tau phenotype in Tau P301S mice but is unable cure the tauopathy
    Raha-Chowdhury, R.
    Goedert, M.
    Spillantini, M. G.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 46 - 46
  • [36] Impairment of Nrf2 signaling in the hippocampus of P301S tauopathy mice model aligns with the cognitive impairment and the associated neuroinflammation
    Mohamed, Ahmed Sabry
    Elkaffas, Mahmoud
    Metwally, Karim
    Abdelfattah, Mahmoud
    Elsery, Eslam Ashraf
    Elshazly, Ahmed
    Gomaa, Hossam Eldin
    Alsayed, Aziza
    El-Desouky, Sara
    El-Gamal, Randa
    Elfarrash, Sara
    JOURNAL OF INFLAMMATION-LONDON, 2024, 21 (01):
  • [37] A novel phosphodiesterase 5 inhibitor, RF26, improves memory impairment and ameliorates tau aggregation and neuroinflammation in the P301S tauopathy mouse model of Alzheimer's disease
    El-desouky, Sara
    Abdel-Halim, Mohammad
    Fathalla, Reem K.
    Abadi, Ashraf H.
    Piazza, Gary A.
    Salama, Mohamed
    El-khodery, Sabry Ahmed
    Youssef, Mohamed A.
    Elfarrash, Sara
    EXPERIMENTAL NEUROLOGY, 2025, 384
  • [38] Accelerated sarcopenia precedes learning and memory impairments in the P301S mouse model of tauopathies and Alzheimer's disease
    Longo, Savannah
    Messi, Maria Laura
    Wang, Zhong-Min
    Meeker, William
    Delbono, Osvaldo
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (04) : 1358 - 1375
  • [39] Disinhibition-like behavior in a P301S mutant tau transgenic mouse model of frontotemporal dementia
    Przybyla, Magdalena
    Stevens, Claire H.
    van der Hoven, Julia
    Harasta, Anne
    Bi, Mian
    Ittner, Arne
    van Hummel, Annika
    Hodges, John R.
    Piguet, Olivier
    Karl, Tim
    Kassiou, Michael
    Housley, Gary D.
    Ke, Yazi D.
    Ittner, Lars M.
    van Eersel, Janet
    NEUROSCIENCE LETTERS, 2016, 631 : 24 - 29
  • [40] TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits
    Wang, Hongjie
    Wang, Ruizhi
    Carrera, Ivan
    Xu, Shaohua
    Lakshmana, Madepalli K.
    ENEURO, 2016, 3 (03) : 9340 - 9351